Float Short %

6.54

Margin Of Safety %

Put/Call OI Ratio

0.2

EPS Next Q Diff

0.18

EPS Last/This Y

-0.49

EPS This/Next Y

0.01

Price

3.16

Target Price

16.1

Analyst Recom

1.08

Performance Q

-37.55

Relative Volume

0.91

Beta

0.96

Ticker: VYGR

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-20	VYGR	3.88	0.22	0.00	3224
2025-03-21	VYGR	3.87	0.22	10.00	3230
2025-03-24	VYGR	3.9	0.17	0.17	2775
2025-03-25	VYGR	3.73	0.17	0.00	2789
2025-03-26	VYGR	3.64	0.17	0.08	2814
2025-03-27	VYGR	3.73	0.16	3.00	2795
2025-03-28	VYGR	3.66	0.16	999.99	2799
2025-03-31	VYGR	3.38	0.18	0.84	2829
2025-04-01	VYGR	3.37	0.18	0.50	2829
2025-04-02	VYGR	3.41	0.18	0.00	2830
2025-04-03	VYGR	3.11	0.18	2.60	2836
2025-04-04	VYGR	3.09	0.19	0.33	2856
2025-04-07	VYGR	3.06	0.19	3.39	2847
2025-04-08	VYGR	2.86	0.21	0.00	2898
2025-04-09	VYGR	3.11	0.21	0.02	2903
2025-04-10	VYGR	2.99	0.21	0.00	2932
2025-04-11	VYGR	3.17	0.21	0.00	2933
2025-04-14	VYGR	3.19	0.20	0.00	2935
2025-04-15	VYGR	3.22	0.20	0.00	2935
2025-04-16	VYGR	3.14	0.20	0.00	2958
2025-04-17	VYGR	3.16	0.20	0.31	2964
2025-04-18	VYGR	3.16	0.20	0.31	2964
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-20	VYGR	3.88	-119.4	-	-1.62
2025-03-21	VYGR	3.87	-119.4	-	-1.62
2025-03-24	VYGR	3.91	-119.4	-	-1.62
2025-03-25	VYGR	3.72	-119.4	-	-1.62
2025-03-26	VYGR	3.64	-119.4	-	-1.62
2025-03-27	VYGR	3.72	-119.4	-	-1.62
2025-03-28	VYGR	3.65	-119.4	-	-1.62
2025-03-31	VYGR	3.38	-119.4	-	-1.62
2025-04-01	VYGR	3.37	-119.4	-	-1.62
2025-04-02	VYGR	3.41	-119.4	-	-1.62
2025-04-03	VYGR	3.11	-119.4	-	-1.62
2025-04-04	VYGR	3.08	-119.4	-	-1.62
2025-04-07	VYGR	3.05	-119.4	-	-1.62
2025-04-08	VYGR	2.85	-119.4	-	-1.62
2025-04-09	VYGR	3.11	-119.4	-	-1.62
2025-04-10	VYGR	2.99	-119.4	-	-1.62
2025-04-11	VYGR	3.16	-119.4	-	-1.62
2025-04-14	VYGR	3.19	-119.4	-	-1.62
2025-04-15	VYGR	3.21	-119.4	-	-1.62
2025-04-16	VYGR	3.14	-119.4	-	-1.62
2025-04-17	VYGR	3.16	-119.4	-	-1.62
2025-04-18	VYGR	3.16	-119.4	-	-1.62
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-20	VYGR	-0.66	-8.04	6.02
2025-03-21	VYGR	-0.66	-8.04	6.02
2025-03-24	VYGR	-0.66	-8.22	6.02
2025-03-25	VYGR	-0.66	-8.22	6.02
2025-03-26	VYGR	-0.66	-8.22	6.27
2025-03-27	VYGR	-0.66	-8.22	6.27
2025-03-28	VYGR	-0.66	-8.22	6.27
2025-03-31	VYGR	-0.66	-8.22	6.27
2025-04-01	VYGR	-0.66	-8.22	6.27
2025-04-02	VYGR	-0.66	-8.22	6.27
2025-04-03	VYGR	-0.66	-8.22	6.27
2025-04-04	VYGR	-0.81	-8.22	6.27
2025-04-07	VYGR	-0.81	-8.27	6.27
2025-04-08	VYGR	-0.81	-8.27	6.27
2025-04-09	VYGR	-0.81	-8.27	6.27
2025-04-10	VYGR	-0.81	-8.27	6.54
2025-04-11	VYGR	-0.81	-8.27	6.54
2025-04-14	VYGR	-0.81	-8.27	6.54
2025-04-15	VYGR	-0.81	-8.27	6.54
2025-04-16	VYGR	-0.81	-8.27	6.54
2025-04-17	VYGR	-0.81	-8.27	6.54
2025-04-18	VYGR	-0.81	-8.27	6.54
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.59

Avg. EPS Est. Current Quarter

-0.44

Avg. EPS Est. Next Quarter

-0.41

Insider Transactions

-0.81

Institutional Transactions

-8.27

Beta

0.96

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

78.4

Max Drawdown 5-Year %

-82.6

Target Price

16.1

P/E

Forward P/E

PEG

P/S

2.18

P/B

0.58

P/Free Cash Flow

EPS

-1.13

Average EPS Est. Cur. Y

-1.62

EPS Next Y. (Est.)

-1.61

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-81.25

Relative Volume

0.91

Return on Equity vs Sector %

-41.7

Return on Equity vs Industry %

-28.3

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.12

EBIT Estimation

Voyager Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 172

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. The company's lead product candidate is VY7523, an anti-tau antibody program for the treatment of alzheimer's disease (AD). Its product pipeline includes VY1706, a tau silencing gene therapy in preclinical trial for the treatment of alzheimer's disease; SOD1 silencing gene therapy program for treating amyotrophic lateral sclerosis in preclinical trial; and vectorized anti-amyloid antibody early research program for the treatment of AD in preclinical trial. The company is also developing VY-FXN01 for treating friedreich's ataxia; and GBA1 gene replacement program to treat parkinson's disease. In addition, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Neurocrine Biosciences, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.

stock quote shares VYGR – Voyager Therapeutics, Inc. Stock Price stock today

news today VYGR – Voyager Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch VYGR – Voyager Therapeutics, Inc. yahoo finance google finance

stock history VYGR – Voyager Therapeutics, Inc. invest stock market

stock prices VYGR premarket after hours

ticker VYGR fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: VYGR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y